期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 51, 期 4, 页码 1563-1565出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01326-06
关键词
-
资金
- NIAID NIH HHS [UC1 AI049514, AI-049514-01, R43 AI060250-01, R43 AI060250] Funding Source: Medline
Substitution of the new diamine antibiotic SQ109 for ethambutol in a mouse model of chronic tuberculosis (TB) improved efficacy of combination drug therapy with first-line TB drugs rifampin and isoniazid, with or without pyrazinamide: at 8 weeks, lung bacteria were 1.5 log(10) lower in SQ109-containing regimens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据